Mr Gregory Hamm

Gregory Hamm (PhD) is associate principal scientist at AstraZeneca (AZ) in Clinical Pharmacology Safety Sciences (CPSS) department from the Biopharmaceutical R&D. He holds a PhD in physics and chemistry from the Paul Verlaine University of Metz in 2010. He is specialized in bioanalysis with high resolution mass spectrometry (HRMS) and mass spectrometry imaging (MSI). As R&D manager in the MS imaging department of ImaBiotech from 2010 to 2016, he developed a new methodology for quantification by MSI and coordinated national or international research program for the company. He joined AstraZeneca MSI team in 2016 and oversees internal drug related studies to provide answers to key biological or pharmaceutical project issues using MSI. He continues to promote the utility of MSI through his role as chairman of the MSI study group for the European Society of Molecular Imaging.